Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T
Division of Epidemiology, Ministry of Public Health, Nonthaburi, Thailand.
J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 15;12(5):500-7. doi: 10.1097/00042560-199608150-00010.
Our objective was to estimate HIV seroconversion rates among commercial sex workers (CSWs) between 1990 and 1991 and to identify the behavioral, demographic, and reproductive determinants of these rates. This study has a prospective (n = 240 with 15 cases) and a cross-sectional component (n = 271 with 34 cases). In November 1990, HIV-negative female CSWs from 24 brothels in Khon Kaen city were interviewed and were followed prospectively for up to 1 year. In March, June, and September 1991, additional HIV-negative CSWs were enrolled and prospectively followed. HIV seroconversion rates were calculated, and the Cox regression model was used to estimate the relative risks of HIV seroconversion from demographic, sexual practice, and reproductive factors, adjusted for the effects of the others, among 232 of the 240 without missing data. Seroprevalence rates were also calculated for the 271 participants enrolled between March and December 1991, and relative risks of HIV seroprevalence were calculated for demographic, sexual practice, and reproductive risk factors among 184 of the 271 without missing data. The average seroprevalence was 12.5% (95% confidence interval 9.6-15.4%). With 1,947 person-months of observation obtained from 240 participants who were uninfected at baseline and seen at least twice during the course of the study, the cumulative incidence of HIV seroconversion between November 1990 and December 1991 was 9.4% (95% confidence interval 5.4-13.4%), and the average incidence rate of HIV seroconversion was 9.2 per 100 person-years (95% confidence interval 4.6-13.9 per 100 person-years). In the multivariate analysis, later date of enrollment into the study, having < 3 months experience as a CSW, and use of injectable contraceptives were the only risk factors that remained significant, with relative risks of 2.1 (95% confidence interval 1.2-3.7) for enrollment 3 months later, 3.8 (95% confidence interval 1.0-14.4) for < 3 months experience as a CSW versus > 3 months experience, and 3.9 (95% confidence interval 1.3-11.8) [corrected] for use of injectable contraceptives. In multivariate analysis of the cross-sectional data with 184 participants, of whom 21 were HIV seropositive, risk of HIV seropositivity increased significantly with current syphilis infection (odds ratio 5.8, 95% confidence interval 1.1-31.0). The results of this study will contribute to a better understanding of the risk factors of infection with HIV and thus allow for better targeting of group-specific interventions, particularly for CSWs and their clients. Further investigation of a possible association between injectable contraceptive use and HIV infection is needed.
我们的目标是估计1990年至1991年间商业性工作者(CSW)中的HIV血清阳转率,并确定这些比率的行为、人口统计学和生殖方面的决定因素。本研究包括前瞻性研究(n = 240,15例)和横断面研究(n = 271,34例)。1990年11月,对孔敬市24家妓院中HIV阴性的女性商业性工作者进行了访谈,并对其进行了长达1年的前瞻性随访。1991年3月、6月和9月,纳入了更多HIV阴性的商业性工作者并进行前瞻性随访。计算了HIV血清阳转率,并使用Cox回归模型估计在240名无缺失数据的参与者中的232名中,人口统计学、性行为和生殖因素导致HIV血清阳转的相对风险,并对其他因素的影响进行了调整。还计算了1991年3月至12月纳入的271名参与者的血清流行率,并在271名无缺失数据的参与者中的184名中计算了人口统计学、性行为和生殖风险因素导致HIV血清阳性的相对风险。平均血清流行率为12.5%(95%置信区间9.6 - 15.4%)。从240名基线时未感染且在研究过程中至少接受两次检查的参与者中获得了1947人月的观察数据,1990年11月至1991年12月期间HIV血清阳转的累积发病率为9.4%(95%置信区间5.4 - 13.4%),HIV血清阳转的平均发病率为每100人年9.2例(95%置信区间每100人年4.6 - 13.9例)。在多变量分析中,研究入组较晚、作为商业性工作者的经验少于3个月以及使用注射用避孕药是仅有的仍具有显著意义的风险因素,入组3个月后相对风险为2.1(95%置信区间1.2 - 3.7),作为商业性工作者经验少于3个月与多于3个月相比相对风险为3.8(95%置信区间1.0 - 14.4),使用注射用避孕药相对风险为3.9(95%置信区间1.3 - 11.8)[校正后]。在对184名参与者的横断面数据进行多变量分析时,其中21名HIV血清阳性,当前梅毒感染会使HIV血清阳性风险显著增加(比值比5.8,95%置信区间1.1 - 31.0)。本研究结果将有助于更好地理解HIV感染的风险因素,从而能够更有针对性地开展针对特定群体的干预措施,特别是针对商业性工作者及其客户。需要进一步调查注射用避孕药使用与HIV感染之间可能存在的关联。